Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrate 4% vs Heparin for PICC Occlusion Prevention
NCT03114722Phase 2Unknown
- Sponsor
- National University Hospital
- Start
- Jul 2017
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of trisodium citrate in catheter occlusion (2 arms), sponsored by National University Hospital. Primary endpoint: Rate of catheter occlusion at 6 months. Status: unknown.
02
Drugs
trisodium citrate
03
Conditions
catheter occlusion
Beyond the preview
Go deeper on NCT03114722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03114722.